{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:06:29Z","timestamp":1789383989889,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Astellas Pharma Inc."},{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncol Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40487-026-00457-4","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:03:12Z","timestamp":1784818992000},"page":"1043-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicians\u2019 Perspectives on the Impact of Different Attributes of Androgen Receptor Pathway Inhibitors on Prostate Cancer Treatment Preferences and Compliance in Mexico"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3063-8388","authenticated-orcid":false,"given":"Mario Escobar","family":"G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Rodr\u00edguez-Leboeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Camargo-Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Caterina","family":"Garc\u00eda-Appendini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Guillermo","family":"Ariza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A.","family":"Madero-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"457_CR1","unstructured":"American Cancer Society. About prostate cancer. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about.html. Accessed Dec 2025."},{"key":"457_CR2","unstructured":"American Cancer Society. Prostate cancer\u2014Introduction. https:\/\/www.cancer.net\/cancer-types\/prostate-cancer\/introduction. Accessed Dec 2025."},{"issue":"7","key":"457_CR3","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, et\u00a0al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336\u201346.","journal-title":"Int J Cancer"},{"issue":"5","key":"457_CR4","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.21037\/tau-2025-103","volume":"14","author":"X Lin","year":"2021","unstructured":"Lin X, Zhi Y. Global epidemiological trends in prostate cancer burden: a comprehensive analysis from Global Burden of Disease Study 2021. Transl Androl Urol. 2021;14(5):1238\u201352.","journal-title":"Transl Androl Urol"},{"key":"457_CR5","unstructured":"American Cancer Society. Prostate cancer risk factors. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/causes-risks-prevention\/risk-factors.html. Accessed Dec 2025."},{"issue":"13","key":"457_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133184","volume":"14","author":"SA Beltran-Ontiveros","year":"2000","unstructured":"Beltran-Ontiveros SA, Fernandez-Galindo MA, Moreno-Ortiz JM, et\u00a0al. Incidence, mortality, and trends of prostate cancer in Mexico from 2000 to 2019: results from the Global Burden of Disease Study 2019. Cancers (Basel). 2000;14(13):3184.","journal-title":"Cancers (Basel)"},{"key":"457_CR7","unstructured":"International Agency for Research on Cancer. Global cancer observatory: cancer today\u2014Prostate cancer mortality data visualization. World Health Organization. https:\/\/gco.iarc.fr\/today\/en\/dataviz\/bars?types=1&mode=population&cancers=27&sort_by=value0&sexes=1&age_start=11. Accessed Jan 2026."},{"issue":"3","key":"457_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41391-023-00775-y","volume":"27","author":"F Turco","year":"2024","unstructured":"Turco F, Gillessen S, Treglia G, et\u00a0al. Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2024;27(3):385\u201392.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"17","key":"457_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27(17):5730.","journal-title":"Molecules"},{"issue":"11","key":"457_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103736","volume":"9","author":"H Bolek","year":"2024","unstructured":"Bolek H, Yazgan SC, Yeked\u00fcz E, et\u00a0al. Androgen receptor pathway inhibitors and drug\u2013drug interactions in prostate cancer. ESMO Open. 2024;9(11):103736.","journal-title":"ESMO Open"},{"issue":"1","key":"457_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3735-1","volume":"17","author":"L Bouwman","year":"2017","unstructured":"Bouwman L, Eeltink CM, Visser O, Janssen J, Maaskant JM. Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation. BMC Cancer. 2017;17(1):739.","journal-title":"BMC Cancer"},{"key":"457_CR12","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/PPA.S101821","volume":"10","author":"KD Stewart","year":"2016","unstructured":"Stewart KD, Johnston JA, Matza LS, et\u00a0al. Preference for pharmaceutical formulation and treatment process attributes. Patient Prefer Adherence. 2016;10:1385\u201399.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"457_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.15386\/mpr-1201","volume":"92","author":"LA Anghel","year":"2019","unstructured":"Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92(2):117\u201322.","journal-title":"Med Pharm Rep"},{"issue":"2","key":"457_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1524-4733.2004.72252.x","volume":"7","author":"R Shikiar","year":"2004","unstructured":"Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004;7(2):204\u201315.","journal-title":"Value Health"},{"issue":"12","key":"457_CR15","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/iju.14101","volume":"26","author":"S Ninomiya","year":"2019","unstructured":"Ninomiya S, Kawahara T, Tatenuma T, et\u00a0al. Preference for enzalutamide capsules versus tablet pills in patients with prostate cancer. Int J Urol. 2019;26(12):1161\u20132.","journal-title":"Int J Urol"},{"issue":"6","key":"457_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.xphs.2017.02.006","volume":"106","author":"RP Gullapalli","year":"2017","unstructured":"Gullapalli RP, Mazzitelli CL. Gelatin and non-gelatin capsule dosage forms. J Pharm Sci. 2017;106(6):1453\u201365.","journal-title":"J Pharm Sci"},{"key":"457_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030236","author":"M Kurczewska-Michalak","year":"2020","unstructured":"Kurczewska-Michalak M, Kardas P, Czajkowski M. Patients\u2019 preferences and willingness to pay for solid forms of oral medications\u2014Results of the discrete choice experiment in Polish outpatients. Pharmaceutics. 2020;12(3):236.","journal-title":"Pharmaceutics"},{"issue":"1","key":"457_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/2041-210X.12857","volume":"9","author":"V Hemming","year":"2018","unstructured":"Hemming V, Burgman MA, Hanea AM, McBride MF, Wintle BC. A practical guide to structured expert elicitation using the IDEA protocol. Methods Ecol Evol. 2018;9(1):169\u201380.","journal-title":"Methods Ecol Evol"},{"key":"457_CR19","doi-asserted-by":"crossref","unstructured":"Budescu DV, Chen E. Identifying expertise to extract the wisdom of crowds. Institute for Operations Research & the Management Sciences (INFORMS); 2015;61(2):267\u201380.","DOI":"10.1287\/mnsc.2014.1909"},{"issue":"4","key":"457_CR20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jval.2018.12.007","volume":"22","author":"S Russo","year":"2019","unstructured":"Russo S, Jongerius C, Faccio F, et\u00a0al. Understanding patients\u2019 preferences: a systematic review of psychological instruments used in patients\u2019 preference and decision studies. Value Health. 2019;22(4):491\u2013501.","journal-title":"Value Health"},{"issue":"1","key":"457_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, et\u00a0al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44\u20137.","journal-title":"Value Health"},{"issue":"7","key":"457_CR22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.drudis.2019.05.001","volume":"24","author":"V Soekhai","year":"2019","unstructured":"Soekhai V, Whichello C, Levitan B, et\u00a0al. Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review. Drug Discov Today. 2019;24(7):1324\u201331.","journal-title":"Drug Discov Today"},{"issue":"2","key":"457_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.eururo.2024.09.017","volume":"87","author":"S Gillessen","year":"2025","unstructured":"Gillessen S, Turco F, Davis ID, et\u00a0al. Management of patients with advanced prostate cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC). Eur Urol. 2025;87(2):157\u2013216.","journal-title":"Eur Urol"},{"issue":"4","key":"457_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041042","volume":"15","author":"H Hummler","year":"2023","unstructured":"Hummler H, Stillhart C, Meilicke L, et\u00a0al. Impact of tablet size and shape on the swallowability in older adults. Pharmaceutics. 2023;15(4):1042.","journal-title":"Pharmaceutics"},{"issue":"2","key":"457_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijpharm.2016.03.007","volume":"512","author":"F Liu","year":"2016","unstructured":"Liu F, Ghaffur A, Bains J, Hamdy S. Acceptability of oral solid medicines in older adults with and without dysphagia: a nested pilot validation questionnaire based observational study. Int J Pharm. 2016;512(2):374\u201381.","journal-title":"Int J Pharm"},{"issue":"5","key":"457_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1012050931018","volume":"23","author":"AB Overgaard","year":"2001","unstructured":"Overgaard AB, Hojsted J, Hansen R, Moller-Sonnergaard J, Christrup LL. Patients\u2019 evaluation of shape, size and colour of solid dosage forms. Pharm World Sci. 2001;23(5):185\u20138.","journal-title":"Pharm World Sci"},{"issue":"11","key":"457_CR27","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1007\/s00520-020-05349-5","volume":"28","author":"AL Bryant","year":"2020","unstructured":"Bryant AL, LeBlanc TW, Albrecht T, et\u00a0al. Oral adherence in adults with acute myeloid leukemia (AML): results of a mixed methods study. Support Care Cancer. 2020;28(11):5157\u201364.","journal-title":"Support Care Cancer"},{"key":"457_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2015.11.015","volume":"55","author":"M Milic","year":"2016","unstructured":"Milic M, Foster A, Rihawi K, Anthoney A, Twelves C. \u201cTablet burden\u201d in patients with metastatic breast cancer. Eur J Cancer. 2016;55:1\u20136.","journal-title":"Eur J Cancer"},{"issue":"2","key":"457_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2217\/fon-2023-0450","volume":"20","author":"DM Chase","year":"2024","unstructured":"Chase DM, Shukla S, Courcy J, et\u00a0al. The power of hope: views of ovarian cancer patients on how maintenance therapy affects their lives (VOCAL). Future Oncol. 2024;20(2):83\u201394.","journal-title":"Future Oncol"},{"issue":"1","key":"457_CR30","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1111\/ajag.12856","volume":"40","author":"A Sefidani Forough","year":"2021","unstructured":"Sefidani Forough A, Lau ETL, Steadman KJ, et\u00a0al. Factors that affect health-care workers\u2019 practices of medication administration to aged care residents with swallowing difficulties: an Australia-wide survey study. Australas J Ageing. 2021;40(1):e79\u201386.","journal-title":"Australas J Ageing"},{"issue":"10","key":"457_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/medicina45100101","volume":"45","author":"V Danileviciute","year":"2009","unstructured":"Danileviciute V, Sveikata A, Adomaitiene V, Gumbrevicius G, Fokas V, Sveikatiene R. Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania. Medicina (Kaunas). 2009;45(10):778\u201384.","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"457_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304573","volume":"19","author":"C Bandiera","year":"2024","unstructured":"Bandiera C, Cardoso E, Locatelli I, et\u00a0al. A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: the OpTAT randomized controlled trial. PLoS ONE. 2024;19(6):e0304573.","journal-title":"PLoS ONE"},{"key":"457_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2022.102159","volume":"94","author":"T Gower","year":"2022","unstructured":"Gower T, Pham J, Jouriles EN, Rosenfield D, Bowen HJ. Cognitive biases in perceptions of posttraumatic growth: a systematic review and meta-analysis. Clin Psychol Rev. 2022;94:102159.","journal-title":"Clin Psychol Rev"}],"container-title":["Oncology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-026-00457-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40487-026-00457-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-026-00457-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:32:20Z","timestamp":1789381940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40487-026-00457-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1007\/s40487-026-00457-4","relation":{},"ISSN":["2366-1070","2366-1089"],"issn-type":[{"value":"2366-1070","type":"print"},{"value":"2366-1089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ana Maria Rodr\u00edguez-LeBoeuf, Selene Camargo-Correa, and Ida Caterina Garc\u00eda-Appendini are employees of IQVIA and received funding from Astellas to conduct this study. Arti Dhar, Isabela Rivas, and Juan Guillermo Ariza reported employment with Astellas. Mario Escobar G\u00f3mez and Pedro A. Madero-Morales have no conflicts of interest to report.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Mexico Center for Clinical Research (confirmation number: 24\/013), an independent ethics and research committee. The research was conducted in accordance with the principles of the Declaration of Helsinki (1964) and its subsequent amendments. All participants provided informed consent to take part in the study and consent for their anonymized responses to be published.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}